Risk Models to Predict Chronic Kidney Disease and Its Progression: A Systematic Review

PLoS Medicine

Volumn 9, Issue 11, 2012, Pages

  Echouffo Tcheugui, Justin B ^a   Kengne, Andre P ^b,c,d,e  

^a EMORY UNIVERSITY   (United States)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; BICARBONATE; BRAIN NATRIURETIC PEPTIDE; HOMOCYSTEINE; PHOSPHATE; TROPONIN T;

CHRONIC KIDNEY DISEASE; DISEASE COURSE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FAILURE; MICROALBUMINURIA; OUTCOME ASSESSMENT; PREDICTION; PROTEINURIA; RECEIVER OPERATING CHARACTERISTIC; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; VALIDATION STUDY;

BIOLOGICAL MARKERS; CALIBRATION; DISEASE PROGRESSION; HUMANS; MODELS, THEORETICAL; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; RISK FACTORS; ROC CURVE;

EID: 84870256739     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001344     Document Type: Review

References (50)

1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, et al. (2007) Prevalence of chronic kidney disease in the United States. JAMA 298: 2038-2047.
2. Zhang QL, Rothenbacher D, (2008) Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health 8: 117.
3. Khan S, Amedia CA Jr, (2008) Economic burden of chronic kidney disease. J Eval Clin Pract 14: 422-434.
4. Fink HA, Ishani A, Taylor BC, Greer NL, MacDonald R, et al. (2012) Screening for, monitoring, and treatment of chronic kidney disease stages 1 to 3: a systematic review for the U.S. Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline. Ann Intern Med 156: 570-581.
5. Uhlig K, Levey AS, (2012) Developing guidelines for chronic kidney disease: we should include all of the outcomes. Ann Intern Med 156: 599-601.
6. Levey AS, Coresh J, (2012) Chronic kidney disease. Lancet 379: 165-180.
7. Whaley-Connell A, Shlipak MG, Inker LA, Kurella Tamura M, Bomback AS, et al. (2012) Awareness of kidney disease and relationship to end-stage renal disease and mortality. Am J Med 125: 661-669.
8. Akbari A, Grimshaw J, Stacey D, Hogg W, Ramsay T, et al. (2012) Change in appropriate referrals to nephrologists after the introduction of automatic reporting of the estimated glomerular filtration rate. CMAJ 184: E269-E276.
9. Moons KG, Kengne AP, Woodward M, Royston P, Vergouwe Y, et al. (2012) Risk prediction models: I. development, internal validation, and assessing the incremental value of a new (bio)marker. Heart 98: 683-690.
10. Moons KG, Kengne AP, Grobbee DE, Royston P, Vergouwe Y, et al. (2012) Risk prediction models: II. external validation, model updating, and impact assessment. Heart 98: 691-698.
11. Reilly BM, Evans AT, (2006) Translating clinical research into clinical practice: impact of using prediction rules to make decisions. Ann Intern Med 144: 201-209.
12. National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39: S1-S266.
13. National Collaborating Centre for Chronic Conditions (2008) Chronic kidney disease: early identification and management of chronic kidney disease in adults in primary and secondary care. NICE clinical guideline 73. London: National Institute for Health and Clinical Excellence. Available: http://www.nice.org.uk/nicemedia/live/12069/42117/42117.pdf. Accessed 10 October 2012.
14. International Society of Nephrology (2012) Clinical practice guidelines. Available: http://www.theisn.org/isn-information/clinical-practice-guidelines/itemid-482. Accessed 5 May 2012.
15. Heemann U, Abramowicz D, Spasovski G, Vanholder R, (2011) Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) guidelines on kidney transplantation: a European Renal Best Practice (ERBP) position statement. Nephrol Dial Transplant 26: 2099-2106.
16. Canadian Society of Nephrology (2008) Guideline document library. Available: http://www.csnscn.ca/site/c.lnKKKOOvHqE/b.8079309/k.799F/Guideline_Document_Library.htm. Accessed 5 May 2012.
17. Kidney Disease: Improving Global Outcomes (2009) Clinical practice guidelines. Available: http://www.kdigo.org/clinical_practice_guidelines/index.php. Accessed 5 May 2012.
18. Japanese Society for Dialysis Therapy (2008) Guidelines. Available: http://www.jsdt.or.jp/guideline.html. Accessed 10 October 2012.
19. Imai E, Yasuda Y, Makino H, (2011) Japan Association of Chronic Kidney Disease Initiatives (J-CKDI). Japan Med Assoc J 54: 403-405.
20. Taiwan Society of Nephrology (2012) History and mission. Available: http://www.tsn.org.tw/englishVersion/History.aspx. Accessed 5 May 2012.
21. Bang H, Vupputuri S, Shoham DA, Klemmer PJ, Falk RJ, et al. (2007) SCreening for Occult REnal Disease (SCORED): a simple prediction model for chronic kidney disease. Arch Intern Med 167: 374-381.
22. Blech I, Katzenellenbogen M, Katzenellenbogen A, Wainstein J, Rubinstein A, et al. (2011) Predicting diabetic nephropathy using a multifactorial genetic model. PLoS ONE 6: e18743 doi:10.1371/journal.pone.0018743.
23. Thakkinstian A, Ingsathit A, Chaiprasert A, Rattanasiri S, Sangthawan P, et al. (2011) A simplified clinical prediction score of chronic kidney disease: a cross-sectional-survey study. BMC Nephrol 12: 45.
24. Kwon KS, Bang H, Bomback AS, Koh DH, Yum JH, et al. (2012) A simple prediction score for kidney disease in the Korean population. Nephrology (Carlton) 17: 278-284.
25. Chien KL, Lin HJ, Lee BC, Hsu HC, Lee YT, et al. (2010) A prediction model for the risk of incident chronic kidney disease. Am J Med 123: 836-846.e2.
26. Ando M, Yanagisawa N, Ajisawa A, Tsuchiya K, Nitta K, (2011) A simple model for predicting incidence of chronic kidney disease in HIV-infected patients. Clin Exp Nephrol 15: 242-247.
27. Jardine MJ, Hata J, Woodward M, Perkovic V, Ninomiya T, et al. (2012) Prediction of kidney-related outcomes in patients with type 2 diabetes. Am J Kidney Dis E-pub ahead of print. doi:10.1053/j.ajkd.2012.1004.1025.
28. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, et al. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470.
29. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, et al. (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612.
30. Fox CS, Gona P, Larson MG, Selhub J, Tofler G, et al. (2010) A multi-marker approach to predict incident CKD and microalbuminuria. J Am Soc Nephrol 21: 2143-2149.
31. O'Seaghdha CM, Yang Q, Wu H, Hwang SJ, Fox CS, (2012) Performance of a genetic risk score for CKD stage 3 in the general population. Am J Kidney Dis 59: 19-24.
32. O'Seaghdha CM, Lyass A, Massaro JM, Meigs JB, Coresh J, et al. (2012) A risk score for chronic kidney disease in the general population. Am J Med 125: 270-277.
33. Tangri N, Stevens LA, Griffith J, Tighiouart H, Djurdjev O, et al. (2011) A predictive model for progression of chronic kidney disease to kidney failure. JAMA 305: 1553-1559.
34. Hippisley-Cox J, Coupland C, (2010) Predicting the risk of chronic kidney disease in men and women in England and Wales: prospective derivation and external validation of the QKidney Scores. BMC Fam Pract 11: 49.
35. Kshirsagar AV, Bang H, Bomback AS, Vupputuri S, Shoham DA, et al. (2008) A simple algorithm to predict incident kidney disease. Arch Intern Med 168: 2466-2473.
36. Collins G, Altman D, (2012) Predicting the risk of chronic kidney disease in the UK: an evaluation of QKidney(R) scores using a primary care database. Br J Gen Pract 62: 243-250.
37. Bang H, Mazumdar M, Kern LM, Shoham DA, August PA, et al. (2008) Validation and comparison of a novel screening guideline for kidney disease: KEEPing SCORED. Arch Intern Med 168: 432-435.
38. Bang H, Mazumdar M, Newman G, Bomback AS, Ballantyne CM, et al. (2009) Screening for kidney disease in vascular patients: SCreening for Occult REnal Disease (SCORED) experience. Nephrol Dial Transplant 24: 2452-2457.
39. Keane WF, Zhang Z, Lyle PA, Cooper ME, de Zeeuw D, et al. (2006) Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL study. Clin J Am Soc Nephrol 1: 761-767.
40. Desai AS, Toto R, Jarolim P, Uno H, Eckardt KU, et al. (2011) Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD. Am J Kidney Dis 58: 717-728.
41. Goto M, Kawamura T, Wakai K, Ando M, Endoh M, et al. (2009) Risk stratification for progression of IgA nephropathy using a decision tree induction algorithm. Nephrol Dial Transplant 24: 1242-1247.
42. Goto M, Wakai K, Kawamura T, Ando M, Endoh M, et al. (2009) A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study. Nephrol Dial Transplant 24: 3068-3074.
43. Wakai K, Kawamura T, Endoh M, Kojima M, Tomino Y, et al. (2006) A scoring system to predict renal outcome in IgA nephropathy: from a nationwide prospective study. Nephrol Dial Transplant 21: 2800-2808.
44. Johnson ES, Thorp ML, Platt RW, Smith DH, (2008) Predicting the risk of dialysis and transplant among patients with CKD: a retrospective cohort study. Am J Kidney Dis 52: 653-660.
45. Landray MJ, Emberson JR, Blackwell L, Dasgupta T, Zakeri R, et al. (2010) Prediction of ESRD and death among people with CKD: the Chronic Renal Impairment in Birmingham (CRIB) prospective cohort study. Am J Kidney Dis 56: 1082-1094.
46. van Dieren S, Beulens JW, Kengne AP, Peelen LM, Rutten GE, et al. (2012) Prediction models for the risk of cardiovascular disease in patients with type 2 diabetes: a systematic review. Heart 98: 360-369.
47. Hallan SI, Ritz E, Lydersen S, Romundstad S, Kvenild K, et al. (2009) Combining GFR and albuminuria to classify CKD improves prediction of ESRD. J Am Soc Nephrol 20: 1069-1077.
48. Halbesma N, Jansen DF, Heymans MW, Stolk RP, de Jong PE, et al. (2011) Development and validation of a general population renal risk score. Clin J Am Soc Nephrol 6: 1731-1738.
49. Alssema M, Newson RS, Bakker SJ, Stehouwer CD, Heymans MW, et al. (2012) One risk assessment tool for cardiovascular disease, type 2 diabetes, and chronic kidney disease. Diabetes Care 35: 741-748.
50. Kent DM, Jafar TH, Hayward RA, Tighiouart H, Landa M, et al. (2007) Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease. J Am Soc Nephrol 18: 1959-1965.